Skip to main content
. 2020 Jun 27;12(6):288–297. doi: 10.4254/wjh.v12.i6.288

Table 4.

Patient comorbidities and management with associated mortality

Variable Mortality overall (n = 58362) Mortality teaching (n = 30382) Mortality non-teaching (n = 27979)
Elixhauser comorbidities
0 4202 (7.2) 3008 (9.9) 1455 (5.2)
1 4085 (7.0) 2734 (9.0) 1287 (4.6)
2 4144 (7.1) 2886 (9.5) 1371 (4.9)
≥ 3 3794 (6.5) 2157 (7.1) 1567 (5.6)
Liver comorbidities
Alcoholic cirrhosisa 4494 (7.7) 2795 (9.2) 1763 (6.3)
Ascites 5953 (10.2) 3585 (11.8) 2266 (8.1)
Hepatic encephalopathy 9338 (16.0) 5165 (17.0) 3973 (14.2)
SBP 11322 (19.4) 8294 (27.3) 1567 (5.6)
Hepatorenal syndrome 23695 (40.6) 12335 (40.6) 11415 (40.8)
Coagulopathy 4844 (8.3) 2917 (9.6) 1931 (6.9)
Hepatocellular carcinoma 7821 (13.4) 4770 (15.7) 2266 (8.1)
Management
Blood transfusion 4319 (7.4) 2643 (8.7) 1735 (6.2)
Balloon tamponade 30290 (51.9) 15616 (51.4) 14857 (53.1)
Portosystemic shunt 8871 (15.2) 5195 (17.1) 2770 (9.9)
a

P > 0.05 in comparison between groups. All data are proportions [n (%)]. Comparisons between groups made with χ2 test. All comparisons had P < 0.001 between groups unless otherwise stated.